[Featured Stock] LAYANS, Following COVID-19 Diagnostic Devices, Medical Detectors... K-Medical Devices' 'Great Leap Forward'

[Asia Economy Reporter Hyungsoo Park] Rayence's stock price is strong following news that export volumes have surged since the COVID-19 pandemic.

At 9:51 a.m. on the 22nd, Rayence was trading at 14,150 KRW, up 10.55% from the previous day.

According to the medical device industry, Rayence's overseas supply volume of medical detectors in the first quarter is estimated to have increased by about 70% compared to the same period last year. Orders from hospitals and clinics are increasing mainly in Europe and China. Overseas distributors are requesting shipments as soon as production is completed, as public hospitals are allocating emergency budgets. Demand for wireless detectors needed for mobile medical services has increased. Domestic demand from public health centers is also rising, leading to expectations of strong first-quarter performance.

Detectors are one of the key components that create digital images when taking X-rays. They detect X-rays that have passed through the subject in the X-ray system and convert them into images visible to the human eye. In particular, Rayence detectors have been praised for maintaining image quality while reducing X-ray dosage. The demand for X-ray equipment surged as chest X-rays were taken up to twice a day to examine pneumonia symptoms in COVID-19 patients.

This content was produced with the assistance of AI translation services.